Vocimagene amiretrorepvec

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Name
Vocimagene amiretrorepvec
Accession Number
DB15331
Type
Biotech
Groups
Investigational
Description

Vocimagene amiretrorepvec is under investigation in clinical trial NCT02576665 (A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma (Toca 6)).

Synonyms
Not Available
External IDs
TOCA 511
Categories
UNII
DC4WO3WA4Q
CAS number
1300724-82-6

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
Not Available
Food Interactions
Not Available

References

General References
Not Available
External Links
Not Available

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
1Active Not RecruitingTreatmentBladder Cancers / Brain Metastasis / Cancer of the Ovary / Colorectal Cancers / Head and Neck Carcinoma / IDH1 Mutated or MGMT Methylated Recurrent HGG (Not Recruiting) / IDH1 Mutated or MGMT Methylated Recurrent High Grade Glioma / IDH1 Mutated Solid Tumors / Locally Advanced or Metastatic Breast Cancer / Locally Advanced or Metastatic Pancreatic Cancer / Lung Cancer Non-Small Cell Cancer (NSCLC) / Malignant Lymphomas / Malignant Neoplasm of Pancreas / Melanoma / Metastatic Colorectal Cancers / Metastatic Melanoma / Metastatic Renal Cell Carcinoma / Sarcomas / Triple Negative Breast Cancer (TNBC)1
1CompletedTreatmentAnaplastic Astrocytoma (AA) / Anaplastic Oligoastrocytoma / Anaplastic Oligodendroglioma (AO) / Glioblastoma Multiforme (GBM)1
1Not Yet RecruitingTreatmentNewly Diagnosed High Grade Glioma (HGG)1
2, 3Active Not RecruitingTreatmentAnaplastic Astrocytoma (AA) / Glioblastoma Multiforme (GBM)1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Taxonomy

Classification
Not classified

Drug created on May 20, 2019 09:15 / Updated on May 21, 2019 12:40